Edetate Disodium USP New Zealand - English - Medsafe (Medicines Safety Authority)

edetate disodium usp

centre for advanced medicine - disodium edetate 150 mg/ml (added as disodium edetate hydrous 166mg) - solution for injection - 150 mg/ml - active: disodium edetate 150 mg/ml (added as disodium edetate hydrous 166mg) excipient: hydrochloric acid sodium hydroxide water for injection

Edetate Disodium 150 New Zealand - English - Medsafe (Medicines Safety Authority)

edetate disodium 150

centre for advanced medicine - disodium edetate 150 mg/ml (added as disodium edetate hydrous 166mg) - solution for injection - 150 mg/ml - active: disodium edetate 150 mg/ml (added as disodium edetate hydrous 166mg) excipient: hydrochloric acid sodium hydroxide water for injection

Edetate Disodium USP (Baily Gibson) New Zealand - English - Medsafe (Medicines Safety Authority)

edetate disodium usp (baily gibson)

dr timothy baily gibson - disodium edetate 150 mg/ml - solution for injection - 150 mg/ml - active: disodium edetate 150 mg/ml excipient: hydrochloric acid sodium hydroxide water for injection

BIOLOGICAL THERAPIES DISODIUM EDETATE SOLUTION 3g/100mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

biological therapies disodium edetate solution 3g/100ml injection vial

orthomolecular medisearch laboratories pty ltd trading as biological therapies - disodium edetate, quantity: 30 mg/ml - injection, concentrated - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, cons

BIOLOGICAL THERAPIES DISODIUM EDETATE 3g + SODIUM ASCORBATE 15g SOLUTION injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

biological therapies disodium edetate 3g + sodium ascorbate 15g solution injection vial

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 150 mg/ml; disodium edetate, quantity: 30 mg/ml - injection, concentrated - excipient ingredients: water for injections - 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, constipation, headache, leg cramps, black stools, oliguria, stupor, convulsions, palsies and coma. chronic lead poisoning causes variable involvement of the central n

BIOLOGICAL THERAPIES DISODIUM EDETATE 3g + SODIUM ASCORBATE 5g 50mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

biological therapies disodium edetate 3g + sodium ascorbate 5g 50ml injection vial

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 100 mg/ml; disodium edetate, quantity: 60 mg/ml - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide - 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, constipation, headache, leg cramps, black stools, oliguria, stupor, convulsions, palsies and coma. chronic lead poisoning causes variable involvement of the central n

endrate- Edetate Disodium, anhydrous injection, solution United States - English - NLM (National Library of Medicine)

endrate- edetate disodium, anhydrous injection, solution

edetate disodium, anhydrous (unii: 8nlq36f6mm) (edetic acid - unii:9g34hu7rv0) - injection, solution - endrate (edetate disodium injection, usp) is indicated in selected patients for the emergency treatment of hypercalcemia and for the control of ventricular arrhythmias associated with digitalis toxicity. endrate (edetate disodium injection, usp) is contraindicated in anuric patients. it is not indicated for the treatment of generalized arteriosclerosis associated with advancing age.